Refining the anesthesia management of the face-lift patient: lessons learned from 1089 consecutive face lifts.

Plastic and reconstructive surgery 2015 Vol.135(3) p. 723-730

Ramanadham SR, Costa CR, Narasimhan K, Coleman JE, Rohrich RJ

관련 도메인

Abstract

[BACKGROUND] The importance of anesthetic technique is often underappreciated in face-lift procedures and is sparsely written about in the literature. Appropriate control of blood pressure, anxiety, pain, and nausea is essential for reducing the complications of face lift, primarily, hematoma risk. This study discusses the standard anesthetic protocol provided at the authors' institution and describes the preoperative, intraoperative, and postoperative management of face-lift patients resulting in low hematoma and complication rates.

[METHODS] One thousand eighty-nine patients who underwent face-lift procedures performed by a single surgeon (R.J.R) were included in a retrospective chart review following institutional review board approval. Patient demographics, operative data including additional ancillary procedures, and the anesthesia regimen were recorded. In addition, postoperative complications and reoperation rates were documented.

[RESULTS] Between 1990 and 2013, 1089 face-lift procedures were performed. Of these, 10 patients developed postoperative hematomas. Benzodiazepines were commonly administered preoperatively to reduce anxiety level. Intraoperatively, a specific regimen and combination of inhalation agents, neuromuscular blockers, antiemetics, antihypertensives, and narcotics was given to control the ease of induction and emergence from anesthesia. Postoperatively, nausea, vomiting, anxiety, pain, and hypertension were treated as needed.

[CONCLUSIONS] The described protocol is safe and has been instituted at the authors' facility for approximately 20 years. The benefit of this regimen is related to the synergy of combination therapy. It is successful in reducing patient anxiety and pain, controlling blood pressure and postoperative emesis, and subsequently results in a reduced risk of hematoma.

[CLINICAL QUESTION/LEVEL OF EVIDENCE] Therapeutic, IV.

추출된 의학 개체 (NER)

유형영어 표현한국어 / 풀이UMLS CUI출처등장
합병증 hematoma 혈종 dict 3
시술 face lift 안면거상술 dict 1
해부 blood scispacy 1
해부 neuromuscular scispacy 1
합병증 hematomas scispacy 1
약물 Benzodiazepines C0005064
Benzodiazepines
scispacy 1
약물 [BACKGROUND] scispacy 1
약물 antiemetics scispacy 1
약물 [CONCLUSIONS] scispacy 1
질환 anxiety C0003467
Anxiety
scispacy 1
질환 pain C0030193
Pain
scispacy 1
질환 nausea C0027497
Nausea
scispacy 1
질환 postoperative hematomas scispacy 1
질환 nausea, scispacy 1
질환 hypertension C0020538
Hypertensive disease
scispacy 1
기타 patient scispacy 1
기타 patients scispacy 1

MeSH Terms

Adult; Aged; Aged, 80 and over; Analgesics, Opioid; Androstanols; Anesthesia; Anesthetics, Inhalation; Anesthetics, Intravenous; Anxiety; Female; Follow-Up Studies; Humans; Incidence; Intraoperative Complications; Male; Methyl Ethers; Midazolam; Middle Aged; Neuromuscular Nondepolarizing Agents; Nitrous Oxide; Postoperative Pain; Patient Satisfaction; Retrospective Studies; Rhytidoplasty; Rocuronium; Sevoflurane; Sufentanil; Texas

🔗 함께 등장하는 도메인

이 논문이 속한 카테고리와 같은 논문에서 자주 함께 다뤄지는 카테고리들

관련 논문